Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 369.00
Bid: 369.00
Ask: 371.00
Change: 5.00 (1.37%)
Spread: 2.00 (0.542%)
Open: 381.50
High: 381.50
Low: 369.00
Prev. Close: 364.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Review & Requisition

25 Sep 2009 16:35

RNS Number : 7118Z
Lupus Capital PLC
25 September 2009
 

25 September 2009

Lupus Capital plc

("Lupus", the "Company" or the "Group")

UPDATE ON BUSINESS REVIEW AND REQUISITION OF GENERAL MEETING

Update on Business Review

The Board announces that Keith Taylor, Chief Executive Officer, and his management team have completed the operational and financial aspects of the business review, announced on 1 July 2009.

Following a number of management actions, which were reported in the Group's interim results announcement on 7 September 2009, the Board believes that the Group's operations have stabilised and are now better placed to trade through current economic conditions which remain difficult. Furthermore, a number of the Group's operations are beginning to reflect the benefits of the actions taken to date.

As part of the review process, the Group's balance sheet and funding positions have been thoroughly re-assessed in light of trading expectations for the short to medium term and the level of covenant headroom put in place under the Group's revised banking facilities. The Board has concluded that the Group's capital structure, following the successful agreement of its revised banking facilities through to June 2012, is adequate, subject to any unforeseen circumstances impacting the Group's financial position.

Further to the announcement of the interim results for the six months ended 30 June 2009, the Board is pleased to confirm that the Group continues to perform in line with its expectations. Whilst market conditions across all geographies remain difficult, the benefits of the recent decisive management actions and other initiatives will underpin the Group's performance into 2010 and beyond.

Requisition of General Meeting

The Board also announces that, at 14.00 hours this afternoon, it received a written requisition from Greg Hutchings (the "Requisition"), former Executive Chairman of Lupus, to convene a general meeting of the Company (the "GM").

Greg Hutchings, Walbrook Trustees (Guernsey) Limited (G. F. Hutchings) and Alliance Trust Pensions Limited (GF Hutchings), as shareholders together holding more than five per cent. of the Company's issued ordinary share capital, have requested that resolutions be put to shareholders at the GM to remove Michael Jackson, Keith Taylor, Paul Felton-Smith and Roland Tate as directors of the Company, and that Greg Hutchings, Giles Daubeney and Fred Hoad be appointed directors of the Company in their place.

The Board will duly consider its position regarding the Requisition over the coming days and will write to shareholders on this subject at the appropriate time.

Enquiries

College Hill

Tel: +44 (0)20 7457 2020

Mark Garraway / Gareth David

Collins Stewart Europe Limited

Tel: +44 (0)20 7523 8350

Mark Dickenson / Tom Hulme

Collins Stewart Europe Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as nominated adviser to Lupus Capital plc and is acting for no-one else in connection with the matters referred to in this announcement and will not be responsible to anyone other than Lupus Capital plc for providing the protections afforded to clients of Collins Stewart Europe Limited nor for providing advice in connection with the Requisition or any other matter referred to herein.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDCXXDGGCU
Date   Source Headline
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution
6th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNotice of Results
28th Dec 20223:53 pmRNSHolding(s) in Company
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.